Gastroesophageal Reflux Disease Market - Top Companies and Manufacturers

Companies Dominating the Gastroesophageal Reflux Disease (GERD) Landscape

AstraZeneca PLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Eisai Co., Ltd.
GSK plc.
Takeda Pharmaceutical Company Limited.
Ironwood Pharmaceuticals, Inc.
Johnson & Johnson Services, Inc.
SFJ Pharmaceuticals
Sebela Pharmaceuticals
Phathom Pharmaceuticals, Inc.
Camber Pharmaceuticals, Inc.

Browse Key Market Insights with Data Illustration:

Gastroesophageal Reflux Disease (GERD) Market Size Forecasts 2036

In the News

AstraZeneca PLC has successfully signed the global license agreement with KYM Biosciences Inc. for the development of CMG901, an antibody-drug conjugate (ADC) targeting Claudin 18.2, a promising therapeutic target in gastric cancers.
Eisai Co., Ltd. and Bliss Biopharmaceutical Co., Ltd. have joined hands to develop BB-1701, an antibody-drug conjugate (ADC). This new drug is expected to have anti-tumor effects on breast, lung, and other solid tumors.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of gastroesophageal reflux disease is estimated at USD 5.24 Billion.

The gastroesophageal reflux disease (GERD) market size was over USD 5.12 Billion in 2023 and is anticipated to reach USD 6.88 Billion by 2036, witnessing around 2.3% CAGR during the forecast period i.e., between 2024-2036. Higher consumption of processed food, increase in digestive issues, and problems caused by contaminated food are the few factors likely to propel the market growth.

North America industry is projected to hold 35% of the revenue share in the 2036, owing to rising aging population in the region which are more prone to gastrointestinal problems.

AstraZeneca PLC, Eisai Co., Ltd., GSK plc., Takeda Pharmaceutical Company Limited., Ironwood Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., SFJ Pharmaceuticals, Sebela Pharmaceuticals, Phathom Pharmaceuticals, Inc., Camber Pharmaceuticals, Inc.

Gastroesophageal Reflux Disease Market - Top Companies and Manufacturers

Companies Dominating the Gastroesophageal Reflux Disease (GERD) Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the gastroesophageal reflux disease market?

Why is the gastroesophageal reflux disease sector gaining traction in near future?

Which region accounted for the largest gastroesophageal reflux disease industry share?

Who are the major gastroesophageal reflux disease players?